Such a curiously-worded headline, to refer to Ozempic specifically – quite a recognizable & understood term at this point! – as just some "Danish diabetes medicine".
I almost expected the source to be some group with a resentment towards Denmark – maybe Greenland separatists? – but no, it's just a Danish university that doesn't want to say 'Ozempic' in the headline directly.
Maybe the university thinks that Ozempic is not a well known brand in Denmark so being vague will get more clicks. 0.4% of them get a Ozempic prescription per year vs 1.7% of Americans per year. Seems crazy when "Nearly 1 out of every 5 Danish jobs created last year was at Novo", but it's possible.
Another possibility is that they don't wanna tarnish a brand that saved the country from recession last year. No point picking fights with industry over some observational study that has no predictive power
I almost expected the source to be some group with a resentment towards Denmark – maybe Greenland separatists? – but no, it's just a Danish university that doesn't want to say 'Ozempic' in the headline directly.